We are live on ! Find out more
LFCR icon

Lifecore Biomedical

124 hedge funds and large institutions have $301M invested in Lifecore Biomedical in 2013 Q2 according to their latest regulatory filings, with 124 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less call options, than puts

Call options by funds: $7K | Put options by funds: $267K

Holders
124
Holders Change
+124
Holders Change %
% of All Funds
4.05%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
124
Increased
Reduced
Closed
Calls
$7K
Puts
$267K
Net Calls
-$260K
Net Calls Change
-$260K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
CCB
76
Cutter & Co Brokerage
Missouri
$386K +$404K +29,200 New
ARTA
77
A.R.T. Advisors
New York
$386K +$405K +29,278 New
DC
78
Deere & Company
Illinois
$381K +$399K +28,845 New
Swiss National Bank
79
Swiss National Bank
Switzerland
$380K +$398K +28,800 New
AllianceBernstein
80
AllianceBernstein
Tennessee
$379K +$397K +28,715 New
DIA
81
Dana Investment Advisors
Wisconsin
$372K +$390K +28,180 New
BA
82
BlackRock Advisors
Delaware
$352K +$369K +26,664 New
NFA
83
Nationwide Fund Advisors
Ohio
$334K +$349K +25,270 New
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
$330K +$345K +24,958 New
WA
85
WealthTrust Axiom
Pennsylvania
$309K +$324K +23,444 New
PCM
86
Palouse Capital Management
Washington
$307K +$321K +23,240 New
AIG
87
American International Group
New York
$298K +$312K +22,596 New
Invesco
88
Invesco
Georgia
$297K +$311K +22,459 New
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
$297K +$311K +22,516 New
Nomura Holdings
90
Nomura Holdings
Japan
$285K +$298K +21,570 New
Manulife (Manufacturers Life Insurance)
91
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$261K +$273K +19,711 New
TAM
92
Tocqueville Asset Management
New York
$244K +$255K +18,474 New
UBS AM
93
UBS AM
Illinois
$243K +$254K +18,399 New
CCMG
94
Clark Capital Management Group
Pennsylvania
$239K +$251K +18,122 New
VRS
95
Virginia Retirement Systems
Virginia
$232K +$243K +17,600 New
EMG
96
Ellington Management Group
Connecticut
$225K +$235K +17,000 New
SIP
97
Stoneridge Investment Partners
Pennsylvania
$222K +$233K +16,834 New
ProShare Advisors
98
ProShare Advisors
Maryland
$218K +$228K +16,523 New
SC
99
Sophrosyne Capital
New York
$211K +$221K +16,000 New
AG
100
Algert Global
California
$190K +$199K +14,359 New

LFCR Hedge Fund Activity: Q2 2013 in Review

124 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2013, worth a combined $301M.

Buyers outnumbered sellers: 124 funds opened new LFCR positions and 0 closed out — a net gain of 124 holders — while 0 added to existing stakes and 0 trimmed.

  • 124 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $301M of Lifecore Biomedical stock for Q2 2013.
  • 124 funds opened new Lifecore Biomedical positions in Q2 2013 and 0 closed out, a net change of +124 holders.

Based on aggregated 13F filings for Q2 2013.